The invention relates to the compounds of formula (I),(see formula I)wherein R1a-R1e, R2a, R2b, R3 and X are defined as in the specification. Theinventivederivatives are tyrosinkinase inhibitors, especially inhibitors of TIE-2, andRaf kinaseinhibitors and may inter alia be used for treating tumors.